{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-025420","form_type":"8-K","ticker":"ACRS","cik":"0001557746","company_name":"Aclaris Therapeutics, Inc.","filed_at":"2026-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.423526+00:00","generated_at":"2026-05-15T16:37:06.387880+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aclaris Therapeutics raises $39.8M via ATM offering of 12.7M shares","bullets":["Sold 12.7 million shares for gross proceeds of $39.8M under ATM agreement from March 2-9, 2026.","Shares purchased by institutional investors including Deep Track Capital.","Sales executed by agents Leerink Partners and Cantor Fitzgerald."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-025420","json":"https://secwatch.observer/filing/0001104659-26-025420.json","markdown":"https://secwatch.observer/filing/0001104659-26-025420.md","text":"https://secwatch.observer/filing/0001104659-26-025420.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926025420/0001104659-26-025420-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926025420/acrs-20260309x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T16:37:06.387880+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}